At Daiichi Sankyo, we are united by a single purpose, to improve lives around the world through innovative medicines. With a legacy of innovation since 1899, a presence in more than 30 countries, and more than 19,000 employees, we are advancing breakthrough therapies in oncology, cardiovascular disease, rare diseases, and immune disorders. Guided by our 2030 vision to "be an innovative global healthcare company contributing to the sustainable development of society", we are shaping a healthier, more hopeful future for patients, their families, and society.
Job Summary
Daiichi Sankyo’s PhD Fellowship Program offers early-career scientists a unique opportunity to launch their careers at the forefront of drug development and innovation focusing on advancing model informed drug development. The role will serve to establish PK/PD/efficacy/safety relationships in clinical settings to drive the development of potential drug candidates. This program is designed for recent PhD graduates and provides direct placement into a full-time role while offering structured development, mentorship, and visibility to leadership.
This particular PhD Fellowship will be within the TA Oncology department with a core focus on Quantitative Clinical Pharmacology.
Program Features:
- Direct Role Placement: Begin in a high-impact, business-critical role matched to your expertise
- Structured Development: Participate in tailored learning, professional skills workshops, and technical training
- Executive Exposure: Gain access to senior leaders and mentors across the organization
- Peer Network: Join a cohort of PhD associates for shared learning and community
- Career Acceleration: Build a long-term path within Daiichi Sankyo through strategic guidance and performance development
Responsibilities
- Perform modeling and simulation in support of clinical development of clinical candidates including non-compartmental analysis, population PK analysis and exposure-response analyses
- Work closely with study and indication leads within QCP to develop skills to serve as PK scientist/study lead towards the end of the fellowship
- Develop Model-Based Drug Development Plans (MBDD) and Clinical Pharmacology plans for early development candidates and work closely with QCP WG leads and non-clinical teams (non-clinical PK, translational science and pharmacology) to identify FIH dosing and early development plans
- Collaborate with advanced pharmacometrics, QSP and bioanalytical teams to advance skills related to Clinical Pharmacology
- Present findings and learnings to QCP leadership and other functions and externally as well
Qualifications
Education Qualifications
- Ph.D. in Clinical Pharmacology, Non-Clinical Pharmacokinetics or Pharmacometrics
- Experience in pharmacokinetic analysis including modeling and simulation and metabolism
- Proficiency in WinNonLin, NONMEM, R and other relevant software
- Strong analytical, problem-solving, and communication skills
- Ability to work effectively in a collaborative, multidisciplinary environment
Travel Requirements
Ability to travel up to 10% of the time.
Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.
Salary Range:
USD$100,960.00 - USD$151,440.00